SLC27A2 and neoplasm: MYCN promotes fatty acid uptake by upregulating fatty acid transport protein 2 (FATP2), which is encoded by SLC27A2. Inhibition of SLC27A2 can block tumor growth in mice, supporting the therapeutic potential of targeting fatty acid metabolism (Tao et al., 2022).